AbCellera Biologics Inc.
|
1.48 Billion USD
|
88.017%
|
Alkermes plc
|
2.13 Billion USD
|
91.653%
|
Agenus Inc.
|
313.91 Million USD
|
43.197%
|
Alnylam Pharmaceuticals, Inc.
|
3.82 Billion USD
|
95.344%
|
Aptorum Group Limited
|
20.64 Million USD
|
-763.906%
|
Ardelyx, Inc.
|
297.57 Million USD
|
40.079%
|
Arrowhead Pharmaceuticals, Inc.
|
765.55 Million USD
|
76.708%
|
Bicycle Therapeutics plc
|
595.34 Million USD
|
70.049%
|
BioXcel Therapeutics, Inc.
|
73.7 Million USD
|
-141.935%
|
ChromaDex Corporation
|
54.96 Million USD
|
-224.414%
|
Chimerix, Inc.
|
212.77 Million USD
|
16.197%
|
Corbus Pharmaceuticals Holdings, Inc.
|
28.27 Million USD
|
-530.689%
|
Caribou Biosciences, Inc.
|
440.96 Million USD
|
59.564%
|
CRISPR Therapeutics AG
|
2.22 Billion USD
|
92.002%
|
Precision BioSciences, Inc.
|
159.78 Million USD
|
-11.597%
|
Dyadic International, Inc.
|
8.21 Million USD
|
-2069.435%
|
Eton Pharmaceuticals, Inc.
|
31.74 Million USD
|
-461.786%
|
Fortress Biotech, Inc.
|
167.52 Million USD
|
-6.438%
|
Lantern Pharma Inc.
|
43.64 Million USD
|
-308.524%
|
HOOKIPA Pharma Inc.
|
161.33 Million USD
|
-10.521%
|
Inhibikase Therapeutics, Inc.
|
14.5 Million USD
|
-1129.168%
|
Incyte Corporation
|
6.78 Billion USD
|
97.371%
|
IO Biotech, Inc.
|
150.71 Million USD
|
-18.308%
|
Jaguar Health, Inc.
|
50.76 Million USD
|
-251.262%
|
Novavax, Inc.
|
1.85 Billion USD
|
90.389%
|
Janux Therapeutics, Inc.
|
380.4 Million USD
|
53.126%
|
Opthea Limited
|
188.79 Million USD
|
5.551%
|
Ligand Pharmaceuticals Incorporated
|
833.06 Million USD
|
78.596%
|
ContextLogic Inc.
|
423 Million USD
|
57.846%
|
MiMedx Group, Inc.
|
239.04 Million USD
|
25.408%
|
Pyxis Oncology, Inc.
|
173.72 Million USD
|
-2.639%
|
TransCode Therapeutics, Inc.
|
5.16 Million USD
|
-3349.155%
|
NextCure, Inc.
|
129.41 Million USD
|
-37.779%
|
Ocuphire Pharma, Inc.
|
53.94 Million USD
|
-230.524%
|
Oncternal Therapeutics, Inc.
|
36.72 Million USD
|
-385.477%
|
Outlook Therapeutics, Inc.
|
32.3 Million USD
|
-452.029%
|
Vaxcyte, Inc.
|
1.4 Billion USD
|
87.335%
|
PDS Biotechnology Corporation
|
59.39 Million USD
|
-200.237%
|
Madrigal Pharmaceuticals, Inc.
|
640.54 Million USD
|
72.163%
|
Pharming Group N.V.
|
462.85 Million USD
|
61.476%
|
Pieris Pharmaceuticals, Inc.
|
38.68 Million USD
|
-360.99%
|
Avidity Biosciences, Inc.
|
628.55 Million USD
|
71.632%
|
Reviva Pharmaceuticals Holdings, Inc.
|
18.92 Million USD
|
-842.264%
|
Reviva Pharmaceuticals Holdings, Inc.
|
18.92 Million USD
|
-842.264%
|
Sangamo Therapeutics, Inc.
|
165.32 Million USD
|
-7.858%
|
Sol-Gel Technologies Ltd.
|
45.28 Million USD
|
-293.736%
|
Acelyrin, Inc.
|
742.69 Million USD
|
75.991%
|
Salarius Pharmaceuticals, Inc.
|
6.58 Million USD
|
-2607.21%
|
SELLAS Life Sciences Group, Inc.
|
6.4 Million USD
|
-2684.804%
|
Summit Therapeutics Inc.
|
202.94 Million USD
|
12.14%
|
Sensei Biotherapeutics, Inc.
|
74.37 Million USD
|
-139.749%
|
Senti Biosciences, Inc.
|
119.48 Million USD
|
-49.234%
|
Stoke Therapeutics, Inc.
|
228.34 Million USD
|
21.911%
|
Syros Pharmaceuticals, Inc.
|
168.17 Million USD
|
-6.028%
|
Alaunos Therapeutics, Inc.
|
8.26 Million USD
|
-2057.945%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
4.77 Million USD
|
-3635.226%
|
Entrada Therapeutics, Inc.
|
469.19 Million USD
|
61.996%
|
VistaGen Therapeutics, Inc.
|
123.65 Million USD
|
-44.203%
|
Wave Life Sciences Ltd.
|
274.94 Million USD
|
35.148%
|
Sorrento Therapeutics, Inc.
|
472.84 Million USD
|
62.289%
|
TRACON Pharmaceuticals, Inc.
|
10.1 Million USD
|
-1664.582%
|
Barinthus Biotherapeutics plc
|
214.5 Million USD
|
16.874%
|
Psyence Biomedical Ltd.
|
1.13 Million USD
|
-15649.643%
|
Phathom Pharmaceuticals, Inc.
|
413.84 Million USD
|
56.913%
|
Immix Biopharma, Inc.
|
19.92 Million USD
|
-794.904%
|
Keros Therapeutics, Inc.
|
370.02 Million USD
|
51.811%
|
MEI Pharma, Inc.
|
41.37 Million USD
|
-330.963%
|
Windtree Therapeutics, Inc.
|
32.4 Million USD
|
-450.241%
|
Xeris Biopharma Holdings, Inc.
|
340.79 Million USD
|
47.678%
|
Rigel Pharmaceuticals, Inc.
|
117.22 Million USD
|
-52.11%
|
Fortress Biotech, Inc.
|
167.52 Million USD
|
-6.438%
|
Precigen, Inc.
|
151.04 Million USD
|
-18.053%
|
Clearside Biomedical, Inc.
|
34.01 Million USD
|
-424.167%
|
AlloVir, Inc.
|
190.79 Million USD
|
6.544%
|
C4 Therapeutics, Inc.
|
376.45 Million USD
|
52.634%
|
Fate Therapeutics, Inc.
|
506.21 Million USD
|
64.776%
|
ImmuCell Corporation
|
43.8 Million USD
|
-307.027%
|
IDEAYA Biosciences, Inc.
|
649.31 Million USD
|
72.539%
|
Onconetix, Inc.
|
88.82 Million USD
|
-100.752%
|
PureTech Health plc
|
693.97 Million USD
|
74.306%
|
VYNE Therapeutics Inc.
|
97.68 Million USD
|
-82.537%
|
Elevation Oncology, Inc.
|
89.09 Million USD
|
-100.145%
|
Kintara Therapeutics, Inc.
|
6.2 Million USD
|
-2775.056%
|
Seer, Inc.
|
436.26 Million USD
|
59.128%
|
Verrica Pharmaceuticals Inc.
|
81.59 Million USD
|
-118.526%
|
Innoviva, Inc.
|
1.24 Billion USD
|
85.661%
|
Aadi Bioscience, Inc.
|
132.42 Million USD
|
-34.653%
|
ESSA Pharma Inc.
|
149.12 Million USD
|
-19.574%
|
GlycoMimetics, Inc.
|
45.31 Million USD
|
-293.479%
|
GT Biopharma, Inc.
|
14.1 Million USD
|
-1163.81%
|
Inhibrx Biosciences, Inc.
|
307.89 Million USD
|
42.087%
|
Akebia Therapeutics, Inc.
|
241.7 Million USD
|
26.227%
|
Catalyst Pharmaceuticals, Inc.
|
471.9 Million USD
|
62.215%
|
Longboard Pharmaceuticals, Inc.
|
50.69 Million USD
|
-251.719%
|
Orchestra BioMed Holdings, Inc.
|
95.21 Million USD
|
-87.278%
|
Alzamend Neuro, Inc.
|
631.58 Thousand USD
|
-28132.17%
|
Rocket Pharmaceuticals, Inc.
|
566.34 Million USD
|
68.515%
|
Aptose Biosciences Inc.
|
12.92 Million USD
|
-1279.844%
|
ZyVersa Therapeutics, Inc.
|
22.11 Million USD
|
-706.316%
|
Soligenix, Inc.
|
9.79 Million USD
|
-1719.997%
|
Century Therapeutics, Inc.
|
360.69 Million USD
|
50.564%
|
Kura Oncology, Inc.
|
448.93 Million USD
|
60.281%
|
TScan Therapeutics, Inc.
|
272.14 Million USD
|
34.48%
|
Intensity Therapeutics, Inc.
|
17.29 Million USD
|
-930.997%
|
Ocean Biomedical, Inc.
|
110.91 Million USD
|
-60.769%
|
CytomX Therapeutics, Inc.
|
205.15 Million USD
|
13.083%
|
Autolus Therapeutics plc
|
375.38 Million USD
|
52.499%
|
Mineralys Therapeutics, Inc.
|
251.63 Million USD
|
29.139%
|
EyePoint Pharmaceuticals, Inc.
|
355.18 Million USD
|
49.798%
|
Eterna Therapeutics Inc.
|
49.13 Million USD
|
-262.922%
|
Adaptive Biotechnologies Corporation
|
661.13 Million USD
|
73.03%
|
GRI Bio, Inc.
|
2.95 Million USD
|
-5932.172%
|
Xenetic Biosciences, Inc.
|
10.6 Million USD
|
-1581.35%
|
Tenaya Therapeutics, Inc.
|
170.51 Million USD
|
-4.572%
|
IGM Biosciences, Inc.
|
423.41 Million USD
|
57.887%
|
INmune Bio, Inc.
|
57 Million USD
|
-212.821%
|
Heron Therapeutics, Inc.
|
222.5 Million USD
|
19.862%
|
SAB Biotherapeutics, Inc.
|
83.94 Million USD
|
-112.424%
|
Pasithea Therapeutics Corp.
|
26.11 Million USD
|
-582.743%
|
Entero Therapeutics, Inc.
|
6.88 Million USD
|
-2490.527%
|
Milestone Pharmaceuticals Inc.
|
75.22 Million USD
|
-137.034%
|
X4 Pharmaceuticals, Inc.
|
147.25 Million USD
|
-21.087%
|
Atara Biotherapeutics, Inc.
|
165.5 Million USD
|
-7.738%
|
Coherus BioSciences, Inc.
|
629.6 Million USD
|
71.679%
|
Verastem, Inc.
|
149.71 Million USD
|
-19.098%
|
Abeona Therapeutics Inc.
|
64 Million USD
|
-178.602%
|
Pliant Therapeutics, Inc.
|
512.15 Million USD
|
65.184%
|
Tonix Pharmaceuticals Holding Corp.
|
154.45 Million USD
|
-15.444%
|
Histogen Inc.
|
19.07 Million USD
|
-834.887%
|
Aprea Therapeutics, Inc.
|
22.65 Million USD
|
-687.239%
|
Surrozen, Inc.
|
46.08 Million USD
|
-286.96%
|
Organovo Holdings, Inc.
|
6.34 Million USD
|
-2708.49%
|
Lixte Biotechnology Holdings, Inc.
|
4.3 Million USD
|
-4038.471%
|
Ovid Therapeutics Inc.
|
144.02 Million USD
|
-23.804%
|
Panbela Therapeutics, Inc.
|
11.8 Million USD
|
-1410.854%
|
CASI Pharmaceuticals, Inc.
|
75.26 Million USD
|
-136.901%
|
Cadrenal Therapeutics, Inc. Common Stock
|
8.51 Million USD
|
-1993.036%
|
Centessa Pharmaceuticals plc
|
362.96 Million USD
|
50.874%
|
Hepion Pharmaceuticals, Inc.
|
18.09 Million USD
|
-885.449%
|
Arcturus Therapeutics Holdings Inc.
|
429.4 Million USD
|
58.475%
|
BioRestorative Therapies, Inc.
|
12.61 Million USD
|
-1313.852%
|
Apollomics, Inc.
|
55.38 Million USD
|
-221.937%
|
Amarin Corporation plc
|
831.68 Million USD
|
78.56%
|
Mesoblast Limited
|
669.15 Million USD
|
73.353%
|
Turnstone Biologics Corp.
|
112.81 Million USD
|
-58.056%
|
Kymera Therapeutics, Inc.
|
575.75 Million USD
|
69.03%
|
Synaptogenix, Inc.
|
31.11 Million USD
|
-473.095%
|
Tiziana Life Sciences Ltd
|
12.18 Million USD
|
-1363.485%
|
Aurinia Pharmaceuticals Inc.
|
548.06 Million USD
|
67.465%
|
BriaCell Therapeutics Corp.
|
5.87 Million USD
|
-2936.497%
|
Monopar Therapeutics Inc.
|
7.34 Million USD
|
-2327.599%
|
Exelixis, Inc.
|
2.94 Billion USD
|
93.94%
|
Better Therapeutics, Inc.
|
22.94 Million USD
|
-677.191%
|
Nurix Therapeutics, Inc.
|
364.53 Million USD
|
51.086%
|
Apellis Pharmaceuticals, Inc.
|
788.73 Million USD
|
77.393%
|
NLS Pharmaceutics AG
|
1.84 Million USD
|
-9555.965%
|
Dermata Therapeutics, Inc.
|
7.97 Million USD
|
-2134.856%
|
Aridis Pharmaceuticals, Inc.
|
14.69 Million USD
|
-1113.413%
|
Gritstone bio, Inc.
|
177.76 Million USD
|
-0.305%
|
Jasper Therapeutics, Inc.
|
95.38 Million USD
|
-86.948%
|
TNF Pharmaceuticals, Inc.
|
17.86 Million USD
|
-898.255%
|
Avid Bioservices, Inc.
|
336.55 Million USD
|
47.019%
|
Insmed Incorporated
|
1.32 Billion USD
|
86.592%
|
Virpax Pharmaceuticals, Inc.
|
9.62 Million USD
|
-1751.938%
|
MediWound Ltd.
|
66.45 Million USD
|
-168.302%
|
OmniAb, Inc.
|
401.98 Million USD
|
55.642%
|
Alector, Inc.
|
621.82 Million USD
|
71.325%
|
Seres Therapeutics, Inc.
|
358.6 Million USD
|
50.276%
|
Checkpoint Therapeutics, Inc.
|
5.37 Million USD
|
-3215.563%
|
Viracta Therapeutics, Inc.
|
56.69 Million USD
|
-214.526%
|
Zai Lab Limited
|
1.03 Billion USD
|
82.793%
|
Revance Therapeutics, Inc.
|
478.45 Million USD
|
62.732%
|
Aura Biosciences, Inc.
|
255.07 Million USD
|
30.095%
|
Lyell Immunopharma, Inc.
|
750.02 Million USD
|
76.226%
|
Immunic, Inc.
|
54.29 Million USD
|
-228.387%
|
Tarsus Pharmaceuticals, Inc.
|
266.22 Million USD
|
33.022%
|
Veracyte, Inc.
|
1.13 Billion USD
|
84.329%
|
InMed Pharmaceuticals Inc.
|
11.82 Million USD
|
-1408.198%
|
FibroGen, Inc.
|
423.52 Million USD
|
57.899%
|
SeaStar Medical Holding Corporation
|
3.51 Million USD
|
-4975.747%
|
Adial Pharmaceuticals, Inc.
|
4.73 Million USD
|
-3664.532%
|
Sonnet BioTherapeutics Holdings, Inc.
|
5.42 Million USD
|
-3184.128%
|
Jazz Pharmaceuticals plc
|
11.39 Billion USD
|
98.435%
|
Cyclacel Pharmaceuticals, Inc.
|
8.8 Million USD
|
-1925.111%
|
Amylyx Pharmaceuticals, Inc.
|
517.45 Million USD
|
65.541%
|
TG Therapeutics, Inc.
|
329.58 Million USD
|
45.899%
|
Galecto, Inc.
|
38.22 Million USD
|
-366.453%
|
Calithera Biosciences, Inc.
|
28.67 Million USD
|
-521.813%
|
Fortrea Holdings Inc.
|
4.35 Billion USD
|
95.908%
|
KalVista Pharmaceuticals, Inc.
|
235.4 Million USD
|
24.253%
|
Aptevo Therapeutics Inc.
|
24.84 Million USD
|
-617.78%
|
XBiotech Inc.
|
227.24 Million USD
|
21.533%
|
Jasper Therapeutics, Inc.
|
95.38 Million USD
|
-86.948%
|
Lyra Therapeutics, Inc.
|
142.6 Million USD
|
-25.043%
|
Foghorn Therapeutics Inc.
|
285.91 Million USD
|
37.635%
|
Y-mAbs Therapeutics, Inc.
|
127.86 Million USD
|
-39.448%
|
Theravance Biopharma, Inc.
|
381.99 Million USD
|
53.322%
|
Ultragenyx Pharmaceutical Inc.
|
1.49 Billion USD
|
88.041%
|
Metagenomi, Inc. Common Stock
|
364.84 Million USD
|
51.127%
|
Vaxxinity, Inc.
|
44.35 Million USD
|
-302.027%
|
BioCryst Pharmaceuticals, Inc.
|
516.96 Million USD
|
65.508%
|
Gain Therapeutics, Inc.
|
18.6 Million USD
|
-858.181%
|
Cartesian Therapeutics, Inc.
|
305.05 Million USD
|
41.547%
|
NexImmune, Inc.
|
8.59 Million USD
|
-1974.844%
|
Creative Medical Technology Holdings, Inc.
|
10.71 Million USD
|
-1564.096%
|
Marker Therapeutics, Inc.
|
17.12 Million USD
|
-941.087%
|
Regeneron Pharmaceuticals, Inc.
|
33.08 Billion USD
|
99.461%
|
Chemomab Therapeutics Ltd.
|
22.15 Million USD
|
-704.975%
|
Scopus BioPharma Inc.
|
392.26 Thousand USD
|
-45356.77%
|
RAPT Therapeutics, Inc.
|
173.32 Million USD
|
-2.874%
|
Ainos, Inc.
|
31.84 Million USD
|
-459.99%
|
Pluri Inc.
|
39.52 Million USD
|
-351.112%
|
Prothena Corporation plc
|
696.38 Million USD
|
74.395%
|
Adaptimmune Therapeutics plc
|
282.61 Million USD
|
36.907%
|
Celularity Inc.
|
143.88 Million USD
|
-23.923%
|
Rallybio Corporation
|
115.62 Million USD
|
-54.222%
|
Cue Biopharma, Inc.
|
61.53 Million USD
|
-189.795%
|
MeiraGTx Holdings plc
|
458.16 Million USD
|
61.082%
|
Omeros Corporation
|
378.26 Million USD
|
52.861%
|
Humacyte, Inc.
|
128.22 Million USD
|
-39.063%
|
Immunocore Holdings plc
|
597 Million USD
|
70.132%
|
Cocrystal Pharma, Inc.
|
31.25 Million USD
|
-470.431%
|
Cidara Therapeutics, Inc.
|
68.53 Million USD
|
-160.194%
|
Blueprint Medicines Corporation
|
1.04 Billion USD
|
83.006%
|
CalciMedica, Inc.
|
12.18 Million USD
|
-1363.365%
|
Cabaletta Bio, Inc.
|
253.65 Million USD
|
29.702%
|
Marinus Pharmaceuticals, Inc.
|
170.9 Million USD
|
-4.332%
|
Scholar Rock Holding Corporation
|
311.03 Million USD
|
42.672%
|
Sana Biotechnology, Inc.
|
565.29 Million USD
|
68.457%
|
Pulmatrix, Inc.
|
33.95 Million USD
|
-425.093%
|
Elicio Therapeutics, Inc.
|
27.14 Million USD
|
-556.859%
|
Vigil Neuroscience, Inc.
|
140.85 Million USD
|
-26.589%
|
Intellia Therapeutics, Inc.
|
1.3 Billion USD
|
86.294%
|
Adlai Nortye Ltd. American Depositary Shares
|
130.18 Million USD
|
-36.963%
|
Cytokinetics, Incorporated
|
824.31 Million USD
|
78.369%
|
Eloxx Pharmaceuticals, Inc.
|
21.12 Million USD
|
-744.156%
|
Nutriband Inc.
|
7.51 Million USD
|
-2272.055%
|
Protara Therapeutics, Inc.
|
78.95 Million USD
|
-125.842%
|
Vor Biopharma Inc.
|
209.82 Million USD
|
15.02%
|
Roivant Sciences Ltd.
|
7.22 Billion USD
|
97.531%
|
Evogene Ltd.
|
51.1 Million USD
|
-248.938%
|
ProKidney Corp.
|
420.55 Million USD
|
57.601%
|
Applied Therapeutics, Inc.
|
54.83 Million USD
|
-225.189%
|
Hoth Therapeutics, Inc.
|
9.52 Million USD
|
-1772.96%
|
BridgeBio Pharma, Inc.
|
546.38 Million USD
|
67.365%
|
CorMedix Inc.
|
82.05 Million USD
|
-117.294%
|
BioLineRx Ltd.
|
63.92 Million USD
|
-178.938%
|
Tango Therapeutics, Inc.
|
402.56 Million USD
|
55.707%
|
Galectin Therapeutics Inc.
|
28.2 Million USD
|
-532.309%
|
Atai Life Sciences N.V.
|
293.47 Million USD
|
39.242%
|
Renovaro Biosciences Inc.
|
163.12 Million USD
|
-9.306%
|
Aerovate Therapeutics, Inc.
|
127.41 Million USD
|
-39.942%
|
Zentalis Pharmaceuticals, Inc.
|
562.02 Million USD
|
68.274%
|
Sagimet Biosciences Inc.
|
96.71 Million USD
|
-84.36%
|
MediciNova, Inc.
|
66.26 Million USD
|
-169.068%
|
Praxis Precision Medicines, Inc.
|
87.94 Million USD
|
-102.746%
|
Cardio Diagnostics Holdings, Inc.
|
4.46 Million USD
|
-3895.886%
|
GeoVax Labs, Inc.
|
9.28 Million USD
|
-1820.788%
|
Axsome Therapeutics, Inc.
|
588.23 Million USD
|
69.687%
|
Biomea Fusion, Inc.
|
199.92 Million USD
|
10.812%
|
PTC Therapeutics, Inc.
|
1.9 Billion USD
|
90.631%
|
Mereo BioPharma Group plc
|
66.49 Million USD
|
-168.141%
|
Cullinan Oncology, Inc.
|
485.09 Million USD
|
63.242%
|
Syndax Pharmaceuticals, Inc.
|
612.88 Million USD
|
70.906%
|
Absci Corporation
|
234.48 Million USD
|
23.955%
|
NRx Pharmaceuticals, Inc.
|
7.31 Million USD
|
-2337.608%
|
4D Molecular Therapeutics, Inc.
|
339.89 Million USD
|
47.539%
|
Dyne Therapeutics, Inc.
|
165.08 Million USD
|
-8.014%
|
Kiniksa Pharmaceuticals, Ltd.
|
526.32 Million USD
|
66.121%
|
Ventyx Biosciences, Inc.
|
277.69 Million USD
|
35.788%
|
Allakos Inc.
|
243.61 Million USD
|
26.805%
|
Imunon, Inc.
|
21.91 Million USD
|
-713.534%
|
Fulcrum Therapeutics, Inc.
|
257.69 Million USD
|
30.805%
|
Corcept Therapeutics Incorporated
|
621.51 Million USD
|
71.31%
|
BioAtla, Inc.
|
119.65 Million USD
|
-49.017%
|
NLS Pharmaceutics AG
|
1.84 Million USD
|
-9555.965%
|
Bio-Path Holdings, Inc.
|
3.22 Million USD
|
-5437.609%
|
Allogene Therapeutics, Inc.
|
642.83 Million USD
|
72.262%
|
Larimar Therapeutics, Inc.
|
95.93 Million USD
|
-85.866%
|
XOMA Corporation
|
234.3 Million USD
|
23.897%
|
Kezar Life Sciences, Inc.
|
221.23 Million USD
|
19.402%
|
Cara Therapeutics, Inc.
|
125.84 Million USD
|
-41.692%
|
aTyr Pharma, Inc.
|
122.06 Million USD
|
-46.076%
|
Aligos Therapeutics, Inc.
|
153.9 Million USD
|
-15.859%
|
Akero Therapeutics, Inc.
|
580.27 Million USD
|
69.271%
|
Viridian Therapeutics, Inc.
|
490.42 Million USD
|
63.641%
|
Eliem Therapeutics, Inc.
|
110.46 Million USD
|
-61.413%
|
EyeGate Pharmaceuticals, Inc.
|
15.15 Million USD
|
-1076.383%
|
Akari Therapeutics, Plc
|
4.35 Million USD
|
-3994.397%
|
Tevogen Bio Holdings Inc.
|
17.03 Million USD
|
-946.59%
|
Halozyme Therapeutics, Inc.
|
1.73 Billion USD
|
89.712%
|
Lexaria Bioscience Corp.
|
3.08 Million USD
|
-5681.836%
|
Sutro Biopharma, Inc.
|
470.73 Million USD
|
62.121%
|
ZIVO Bioscience, Inc.
|
555.71 Thousand USD
|
-31986.771%
|
Orgenesis Inc.
|
14.55 Million USD
|
-1125.337%
|
Entera Bio Ltd.
|
11.76 Million USD
|
-1415.606%
|
GH Research PLC
|
226.3 Million USD
|
21.206%
|
Lisata Therapeutics, Inc.
|
54.69 Million USD
|
-226.016%
|
Reneo Pharmaceuticals, Inc.
|
107.43 Million USD
|
-65.97%
|
Xencor, Inc.
|
952.69 Million USD
|
81.283%
|
60 Degrees Pharmaceuticals, Inc.
|
7.78 Million USD
|
-2190.805%
|
Replimune Group, Inc.
|
487.72 Million USD
|
63.44%
|
Coeptis Therapeutics Holdings, Inc.
|
8.07 Million USD
|
-2109.256%
|
Vanda Pharmaceuticals Inc.
|
648.44 Million USD
|
72.502%
|
Lexaria Bioscience Corp.
|
3.08 Million USD
|
-5681.836%
|
Portage Biotech Inc.
|
7.77 Million USD
|
-2192.21%
|
Cardio Diagnostics Holdings, Inc.
|
4.46 Million USD
|
-3895.886%
|
Olema Pharmaceuticals, Inc.
|
276.94 Million USD
|
35.615%
|
OncoCyte Corporation
|
74.89 Million USD
|
-138.091%
|
Qualigen Therapeutics, Inc.
|
2.03 Million USD
|
-8669.761%
|
Processa Pharmaceuticals, Inc.
|
5.78 Million USD
|
-2981.424%
|
Purple Biotech Ltd.
|
44.3 Million USD
|
-302.49%
|
CollPlant Biotechnologies Ltd.
|
34.12 Million USD
|
-422.508%
|
scPharmaceuticals Inc.
|
94.47 Million USD
|
-88.731%
|
ProMIS Neurosciences, Inc.
|
18.04 Million USD
|
-888.149%
|
HilleVax, Inc.
|
344.43 Million USD
|
48.231%
|
NeuroSense Therapeutics Ltd.
|
3.17 Million USD
|
-5514.326%
|
Tharimmune, Inc.
|
10.94 Million USD
|
-1528.948%
|
Genprex, Inc.
|
10.67 Million USD
|
-1571.051%
|
Neumora Therapeutics, Inc. Common Stock
|
496.19 Million USD
|
64.064%
|
Atossa Therapeutics, Inc.
|
96.25 Million USD
|
-85.254%
|
XTL Biopharmaceuticals Ltd.
|
2.42 Million USD
|
-7250.0%
|
Virios Therapeutics, Inc.
|
4.16 Million USD
|
-4180.723%
|
OKYO Pharma Limited
|
1.54 Million USD
|
-11469.141%
|
Savara Inc.
|
177.56 Million USD
|
-0.421%
|
Curis, Inc.
|
77.28 Million USD
|
-130.728%
|
Daré Bioscience, Inc.
|
21.28 Million USD
|
-737.84%
|
Carmell Therapeutics Corporation
|
63.94 Million USD
|
-178.834%
|
Titan Pharmaceuticals, Inc.
|
8.08 Million USD
|
-2105.182%
|
Achieve Life Sciences, Inc.
|
19.37 Million USD
|
-820.505%
|
BeiGene, Ltd.
|
5.8 Billion USD
|
96.928%
|
Kiromic BioPharma, Inc.
|
12.16 Million USD
|
-1365.289%
|
Revolution Medicines, Inc. Warrant
|
2.08 Billion USD
|
91.463%
|
Protagonist Therapeutics, Inc.
|
357.95 Million USD
|
50.186%
|
Erasca, Inc.
|
395.29 Million USD
|
54.892%
|
bluebird bio, Inc.
|
619.16 Million USD
|
71.201%
|
Protagenic Therapeutics, Inc.
|
4.32 Million USD
|
-4024.353%
|
BioMarin Pharmaceutical Inc.
|
6.84 Billion USD
|
97.394%
|
DBV Technologies S.A.
|
182.98 Million USD
|
2.555%
|
Protagenic Therapeutics, Inc.
|
4.32 Million USD
|
-4024.353%
|
Moderna, Inc.
|
18.42 Billion USD
|
99.032%
|
Vincerx Pharma, Inc.
|
18.21 Million USD
|
-878.816%
|
Fresh Tracks Therapeutics, Inc.
|
11.58 Million USD
|
-1439.021%
|
Molecular Templates, Inc.
|
35.38 Million USD
|
-403.945%
|
Acrivon Therapeutics, Inc. Common Stock
|
138.26 Million USD
|
-28.963%
|
Travere Therapeutics, Inc.
|
788.91 Million USD
|
77.398%
|
Monte Rosa Therapeutics, Inc.
|
303.75 Million USD
|
41.298%
|
Spruce Biosciences, Inc.
|
103.94 Million USD
|
-71.542%
|
Celldex Therapeutics, Inc.
|
465.62 Million USD
|
61.705%
|
Cogent Biosciences, Inc.
|
313.43 Million USD
|
43.111%
|
MacroGenics, Inc.
|
306.82 Million USD
|
41.884%
|
RenovoRx, Inc.
|
1.46 Million USD
|
-12063.097%
|
Adicet Bio, Inc.
|
207.29 Million USD
|
13.982%
|
Prime Medicine, Inc.
|
193.85 Million USD
|
8.016%
|
Aditxt, Inc.
|
44.57 Million USD
|
-299.995%
|
Adagene Inc.
|
115.72 Million USD
|
-54.077%
|
Estrella Immunopharma, Inc.
|
4.45 Million USD
|
-3903.22%
|
Quantum-Si incorporated
|
298.25 Million USD
|
40.214%
|
Maravai LifeSciences Holdings, Inc.
|
1.48 Billion USD
|
88.012%
|
Acurx Pharmaceuticals, Inc.
|
7.7 Million USD
|
-2212.987%
|
Voyager Therapeutics, Inc.
|
351.28 Million USD
|
49.24%
|
SciSparc Ltd.
|
11.18 Million USD
|
-1494.625%
|
Vericel Corporation
|
353.65 Million USD
|
49.581%
|
Revelation Biosciences, Inc.
|
12.21 Million USD
|
-1360.057%
|
Minerva Neurosciences, Inc.
|
56.9 Million USD
|
-213.373%
|
Generation Bio Co.
|
374.75 Million USD
|
52.42%
|
Astria Therapeutics, Inc.
|
254.66 Million USD
|
29.982%
|
Black Diamond Therapeutics, Inc.
|
158.56 Million USD
|
-12.452%
|
Arcutis Biotherapeutics, Inc.
|
341.36 Million USD
|
47.765%
|
Invivyd, Inc.
|
229.18 Million USD
|
22.196%
|
Relay Therapeutics, Inc.
|
843.98 Million USD
|
78.873%
|
Quoin Pharmaceuticals, Ltd.
|
12.16 Million USD
|
-1365.253%
|
Spero Therapeutics, Inc.
|
182.39 Million USD
|
2.236%
|
Artelo Biosciences, Inc.
|
20.42 Million USD
|
-773.046%
|
2seventy bio, Inc.
|
565.42 Million USD
|
68.464%
|
ADMA Biologics, Inc.
|
329.18 Million USD
|
45.832%
|
Clene Inc.
|
52.34 Million USD
|
-240.672%
|
Capricor Therapeutics, Inc.
|
58.73 Million USD
|
-203.589%
|
Boundless Bio, Inc. Common Stock
|
129.89 Million USD
|
-37.274%
|
GeoVax Labs, Inc.
|
9.28 Million USD
|
-1820.788%
|
Recursion Pharmaceuticals, Inc.
|
653.69 Million USD
|
72.723%
|
Citius Pharmaceuticals, Inc.
|
103.61 Million USD
|
-72.096%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
130.38 Million USD
|
-36.756%
|
Relmada Therapeutics, Inc.
|
97.55 Million USD
|
-82.786%
|
Finch Therapeutics Group, Inc.
|
70.99 Million USD
|
-151.153%
|
ALX Oncology Holdings Inc.
|
242.55 Million USD
|
26.486%
|
Vir Biotechnology, Inc.
|
1.96 Billion USD
|
90.903%
|
Evaxion Biotech A/S
|
12.88 Million USD
|
-1283.476%
|
Ocular Therapeutix, Inc.
|
252.06 Million USD
|
29.259%
|
Verve Therapeutics, Inc.
|
752.68 Million USD
|
76.31%
|
Trevena, Inc.
|
40.6 Million USD
|
-339.136%
|
Surrozen, Inc.
|
46.08 Million USD
|
-286.96%
|
Tyra Biosciences, Inc.
|
225.85 Million USD
|
21.051%
|
Cingulate Inc.
|
3.49 Million USD
|
-5007.096%
|
Galmed Pharmaceuticals Ltd.
|
16.62 Million USD
|
-972.289%
|
Unity Biotechnology, Inc.
|
65.69 Million USD
|
-171.443%
|
Tenax Therapeutics, Inc.
|
11.68 Million USD
|
-1426.031%
|
Terns Pharmaceuticals, Inc.
|
268.51 Million USD
|
33.594%
|
ACADIA Pharmaceuticals Inc.
|
748.95 Million USD
|
76.192%
|
Connect Biopharma Holdings Limited
|
125.89 Million USD
|
-41.638%
|
Clearmind Medicine Inc.
|
4.32 Million USD
|
-4023.38%
|
Kronos Bio, Inc.
|
213.27 Million USD
|
16.395%
|
Bolt Biotherapeutics, Inc.
|
159.78 Million USD
|
-11.595%
|
CERo Therapeutics Holdings, Inc.
|
8.56 Million USD
|
-1982.924%
|
Viking Therapeutics, Inc.
|
368.49 Million USD
|
51.61%
|
Statera Biopharma, Inc.
|
21.16 Million USD
|
-742.294%
|
ImmunityBio, Inc.
|
504.45 Million USD
|
64.653%
|
Korro Bio, Inc.
|
221.66 Million USD
|
19.558%
|
Kineta, Inc.
|
10.28 Million USD
|
-1634.374%
|
BioVie Inc.
|
25.2 Million USD
|
-607.349%
|
Codexis, Inc.
|
136.56 Million USD
|
-30.572%
|
Celularity Inc.
|
143.88 Million USD
|
-23.923%
|
Crinetics Pharmaceuticals, Inc.
|
635.35 Million USD
|
71.935%
|
Celcuity Inc.
|
191.21 Million USD
|
6.751%
|
Virax Biolabs Group Limited
|
5.48 Million USD
|
-3151.495%
|
Cibus, Inc.
|
544.41 Million USD
|
67.247%
|
Eledon Pharmaceuticals, Inc.
|
125.89 Million USD
|
-41.636%
|
eFFECTOR Therapeutics, Inc.
|
20.54 Million USD
|
-767.947%
|
IN8bio, Inc.
|
33.7 Million USD
|
-428.971%
|
Kodiak Sciences Inc.
|
479.37 Million USD
|
62.803%
|
Annexon, Inc.
|
297.67 Million USD
|
40.099%
|
Adverum Biotechnologies, Inc.
|
173.01 Million USD
|
-3.064%
|
Assembly Biosciences, Inc.
|
137.46 Million USD
|
-29.71%
|
Avalo Therapeutics, Inc.
|
20.99 Million USD
|
-749.383%
|
Ionis Pharmaceuticals, Inc.
|
2.99 Billion USD
|
94.037%
|
Eyenovia, Inc.
|
28.77 Million USD
|
-519.579%
|
Puma Biotechnology, Inc.
|
230.52 Million USD
|
22.651%
|
Conduit Pharmaceuticals Inc.
|
7.22 Million USD
|
-2368.314%
|
Xilio Therapeutics, Inc.
|
60.92 Million USD
|
-192.668%
|
Arcellx, Inc.
|
825.13 Million USD
|
78.39%
|
Cardiff Oncology, Inc.
|
81.63 Million USD
|
-118.419%
|
Enanta Pharmaceuticals, Inc.
|
462.27 Million USD
|
61.428%
|
Regulus Therapeutics Inc.
|
30.75 Million USD
|
-479.873%
|
Moolec Science SA
|
24.05 Million USD
|
-641.378%
|
Acumen Pharmaceuticals, Inc.
|
310.12 Million USD
|
42.504%
|
Geron Corporation
|
394.07 Million USD
|
54.752%
|
LAVA Therapeutics N.V.
|
101.71 Million USD
|
-75.313%
|
Royalty Pharma plc
|
16.38 Billion USD
|
98.912%
|
Atea Pharmaceuticals, Inc.
|
594.96 Million USD
|
70.03%
|
Greenwich LifeSciences, Inc.
|
6.99 Million USD
|
-2449.188%
|
TFF Pharmaceuticals, Inc.
|
12.02 Million USD
|
-1382.55%
|
Mersana Therapeutics, Inc.
|
226.06 Million USD
|
21.122%
|
Humacyte, Inc.
|
128.22 Million USD
|
-39.063%
|
Structure Therapeutics Inc.
|
482.01 Million USD
|
63.007%
|
89bio, Inc.
|
596.26 Million USD
|
70.096%
|
PMV Pharmaceuticals, Inc.
|
252.15 Million USD
|
29.284%
|
Avenue Therapeutics, Inc.
|
1.85 Million USD
|
-9538.432%
|
Genelux Corporation
|
27.89 Million USD
|
-539.268%
|
Trevi Therapeutics, Inc.
|
89.4 Million USD
|
-99.446%
|
Lexicon Pharmaceuticals, Inc.
|
229.42 Million USD
|
22.281%
|
Notable Labs, Ltd.
|
19.54 Million USD
|
-812.497%
|
Liquidia Corporation
|
120.43 Million USD
|
-48.061%
|
Mustang Bio, Inc.
|
17.74 Million USD
|
-905.022%
|
Immunovant, Inc.
|
666.71 Million USD
|
73.255%
|
Quantum-Si incorporated
|
298.25 Million USD
|
40.214%
|
Arbutus Biopharma Corporation
|
144.4 Million USD
|
-23.483%
|
DiaMedica Therapeutics Inc.
|
54.16 Million USD
|
-229.23%
|
Vera Therapeutics, Inc.
|
175.54 Million USD
|
-1.575%
|
Acasti Pharma Inc.
|
73.3 Million USD
|
-143.262%
|
MiNK Therapeutics, Inc.
|
4.55 Million USD
|
-3816.959%
|
Pasithea Therapeutics Corp.
|
26.11 Million USD
|
-582.743%
|
Xenon Pharmaceuticals Inc.
|
964.79 Million USD
|
81.518%
|
Elevai Labs, Inc. Common Stock
|
5.18 Million USD
|
-3335.719%
|
NeuroBo Pharmaceuticals, Inc.
|
22.78 Million USD
|
-682.718%
|
Tempest Therapeutics, Inc.
|
51.6 Million USD
|
-245.544%
|
Soleno Therapeutics, Inc.
|
180.69 Million USD
|
1.317%
|
PepGen Inc.
|
143.05 Million USD
|
-24.648%
|
Moleculin Biotech, Inc.
|
38.21 Million USD
|
-366.575%
|
United Therapeutics Corporation
|
7.16 Billion USD
|
97.512%
|
Nuvectis Pharma, Inc.
|
19.18 Million USD
|
-829.429%
|
Solid Biosciences Inc.
|
164.93 Million USD
|
-8.107%
|
BriaCell Therapeutics Corp.
|
5.87 Million USD
|
-2936.497%
|
Immuneering Corporation
|
102.58 Million USD
|
-73.819%
|
Lixte Biotechnology Holdings, Inc.
|
4.3 Million USD
|
-4038.471%
|
Silo Pharma, Inc.
|
7.74 Million USD
|
-2201.933%
|
Belite Bio, Inc
|
94.64 Million USD
|
-88.406%
|
XOMA Corporation
|
234.3 Million USD
|
23.897%
|
ARS Pharmaceuticals, Inc.
|
233.18 Million USD
|
23.533%
|
Bionomics Limited
|
27.64 Million USD
|
-544.907%
|
Apogee Therapeutics, Inc.
|
401.4 Million USD
|
55.578%
|
Alpha Tau Medical Ltd.
|
107.38 Million USD
|
-66.044%
|
uniQure N.V.
|
831.68 Million USD
|
78.56%
|
Cassava Sciences, Inc.
|
151.66 Million USD
|
-17.571%
|
Estrella Immunopharma, Inc.
|
4.45 Million USD
|
-3903.22%
|
Poseida Therapeutics, Inc.
|
273.88 Million USD
|
34.896%
|
Forte Biosciences, Inc.
|
38.98 Million USD
|
-357.442%
|
Anebulo Pharmaceuticals, Inc.
|
4.07 Million USD
|
-4277.756%
|
Enlivex Therapeutics Ltd.
|
36.83 Million USD
|
-384.133%
|
Conduit Pharmaceuticals Inc.
|
7.22 Million USD
|
-2368.314%
|
SeaStar Medical Holding Corporation
|
3.51 Million USD
|
-4975.747%
|
FibroBiologics, Inc. Common Stock
|
11.82 Million USD
|
-1408.426%
|
Altimmune, Inc.
|
210.64 Million USD
|
15.348%
|
Amicus Therapeutics, Inc.
|
777.88 Million USD
|
77.077%
|
Alpha Tau Medical Ltd.
|
107.38 Million USD
|
-66.044%
|
Compugen Ltd.
|
121.33 Million USD
|
-46.959%
|
Peak Bio, Inc.
|
2.59 Million USD
|
-6767.585%
|
Zevra Therapeutics, Inc.
|
172.32 Million USD
|
-3.472%
|
Benitec Biopharma Inc.
|
52.21 Million USD
|
-241.527%
|
Spyre Therapeutics, Inc.
|
341.85 Million USD
|
47.841%
|
NKGen Biotech, Inc. Common Stock
|
34.77 Million USD
|
-412.786%
|
Zura Bio Limited
|
100.84 Million USD
|
-76.82%
|
PolyPid Ltd.
|
15.37 Million USD
|
-1059.973%
|
Aileron Therapeutics, Inc.
|
119.28 Million USD
|
-49.482%
|
NKGen Biotech, Inc. Warrants
|
34.77 Million USD
|
-412.786%
|
Instil Bio, Inc.
|
325.63 Million USD
|
45.241%
|
argenx SE
|
4.54 Billion USD
|
96.075%
|
Immunome, Inc.
|
148.54 Million USD
|
-20.042%
|
Compass Therapeutics, Inc.
|
156.87 Million USD
|
-13.664%
|
Verona Pharma plc
|
308.12 Million USD
|
42.13%
|
enGene Holdings Inc. Warrants
|
86.95 Million USD
|
-105.052%
|
Shattuck Labs, Inc.
|
159.56 Million USD
|
-11.749%
|
CervoMed Inc.
|
9.97 Million USD
|
-1688.023%
|
LENZ Therapeutics, Inc.
|
188.45 Million USD
|
5.383%
|
Plus Therapeutics, Inc.
|
11.38 Million USD
|
-1465.78%
|
Dianthus Therapeutics, Inc.
|
179.4 Million USD
|
0.61%
|
Moolec Science SA
|
24.05 Million USD
|
-641.378%
|
Enveric Biosciences, Inc.
|
6.11 Million USD
|
-2814.779%
|
Inovio Pharmaceuticals, Inc.
|
172.94 Million USD
|
-3.103%
|
AnaptysBio, Inc.
|
452.38 Million USD
|
60.585%
|
Design Therapeutics, Inc.
|
289.64 Million USD
|
38.438%
|
Leap Therapeutics, Inc.
|
72.82 Million USD
|
-144.849%
|
NeurAxis, Inc.
|
509.49 Thousand USD
|
-34897.39%
|
Seelos Therapeutics, Inc.
|
5.41 Million USD
|
-3191.085%
|
Lumos Pharma, Inc.
|
40.63 Million USD
|
-338.779%
|
Achilles Therapeutics plc
|
161.45 Million USD
|
-10.439%
|
enGene Holdings Inc. Common Stock
|
86.95 Million USD
|
-105.052%
|
180 Life Sciences Corp.
|
5.25 Million USD
|
-3290.281%
|
Opiant Pharmaceuticals, Inc.
|
70.42 Million USD
|
-153.183%
|
CERo Therapeutics Holdings, Inc.
|
8.56 Million USD
|
-1982.924%
|
Nutriband Inc.
|
7.51 Million USD
|
-2272.055%
|
ORIC Pharmaceuticals, Inc.
|
254.68 Million USD
|
29.988%
|
CG Oncology, Inc. Common stock
|
199.3 Million USD
|
10.532%
|
Fractyl Health, Inc. Common Stock
|
76.21 Million USD
|
-133.967%
|
Rani Therapeutics Holdings, Inc.
|
57.91 Million USD
|
-207.879%
|
MoonLake Immunotherapeutics
|
526.54 Million USD
|
66.135%
|
Palisade Bio, Inc.
|
14.05 Million USD
|
-1168.937%
|
Tourmaline Bio, Inc.
|
210.29 Million USD
|
15.209%
|
Beam Therapeutics Inc.
|
1.45 Billion USD
|
87.785%
|
Neurogene Inc.
|
222.57 Million USD
|
19.887%
|
Mirum Pharmaceuticals, Inc.
|
646.62 Million USD
|
72.424%
|
AEON Biopharma, Inc.
|
6.84 Million USD
|
-2504.982%
|
CARGO Therapeutics, Inc. Common Stock
|
453.03 Million USD
|
60.641%
|
Sesen Bio, Inc.
|
189.17 Million USD
|
5.742%
|
Enliven Therapeutics, Inc.
|
271.86 Million USD
|
34.412%
|
Kiora Pharmaceuticals, Inc.
|
13.71 Million USD
|
-1200.413%
|
Iovance Biotherapeutics, Inc.
|
780.35 Million USD
|
77.15%
|
Taysha Gene Therapies, Inc.
|
266.99 Million USD
|
33.215%
|
Athira Pharma, Inc.
|
160.24 Million USD
|
-11.274%
|
Vaccinex, Inc.
|
3.63 Million USD
|
-4810.796%
|
HCW Biologics Inc.
|
28.51 Million USD
|
-525.353%
|
XOMA Corporation
|
234.3 Million USD
|
23.897%
|
Nektar Therapeutics
|
398.03 Million USD
|
55.202%
|
Arvinas, Inc.
|
1.3 Billion USD
|
86.332%
|
Tevogen Bio Holdings Inc.
|
17.03 Million USD
|
-946.59%
|
Merus N.V.
|
458.49 Million USD
|
61.109%
|
Omega Therapeutics, Inc.
|
204.36 Million USD
|
12.749%
|
Quince Therapeutics, Inc.
|
180.2 Million USD
|
1.05%
|
Rezolute, Inc.
|
132.73 Million USD
|
-34.334%
|
Clene Inc.
|
52.34 Million USD
|
-240.672%
|
Indaptus Therapeutics, Inc.
|
14.92 Million USD
|
-1094.803%
|
BeyondSpring Inc.
|
24.8 Million USD
|
-618.764%
|
Synlogic, Inc.
|
75.55 Million USD
|
-136.017%
|
Allarity Therapeutics, Inc.
|
11.86 Million USD
|
-1403.212%
|
Phio Pharmaceuticals Corp.
|
9.36 Million USD
|
-1804.218%
|
Peak Bio, Inc.
|
2.59 Million USD
|
-6767.585%
|
Werewolf Therapeutics, Inc.
|
174.83 Million USD
|
-1.989%
|
Krystal Biotech, Inc.
|
818.35 Million USD
|
78.211%
|
Karyopharm Therapeutics Inc.
|
240.43 Million USD
|
25.839%
|
SpringWorks Therapeutics, Inc.
|
725.78 Million USD
|
75.432%
|
Lipella Pharmaceuticals Inc.
|
3.57 Million USD
|
-4884.689%
|
MannKind Corporation
|
475.19 Million USD
|
62.476%
|
Ikena Oncology, Inc.
|
192.09 Million USD
|
7.174%
|
Cyclerion Therapeutics, Inc.
|
13.37 Million USD
|
-1233.266%
|
Gyre Therapeutics, Inc.
|
116.53 Million USD
|
-53.005%
|
Gossamer Bio, Inc.
|
311.91 Million USD
|
42.834%
|
CohBar, Inc.
|
16.36 Million USD
|
-989.543%
|
Cognition Therapeutics, Inc.
|
35.16 Million USD
|
-407.098%
|
NRx Pharmaceuticals, Inc.
|
7.31 Million USD
|
-2337.608%
|
Legend Biotech Corporation
|
1.84 Billion USD
|
90.354%
|
Mural Oncology plc
|
301.74 Million USD
|
40.907%
|
Biora Therapeutics, Inc.
|
31.21 Million USD
|
-471.235%
|
PaxMedica, Inc. Common Stock
|
5.68 Million USD
|
-3039.054%
|
Disc Medicine, Inc.
|
367.99 Million USD
|
51.545%
|
Champions Oncology, Inc.
|
26.13 Million USD
|
-582.347%
|
REGENXBIO Inc.
|
573.97 Million USD
|
68.934%
|
Ensysce Biosciences, Inc.
|
2.7 Million USD
|
-6484.395%
|
Anavex Life Sciences Corp.
|
154.38 Million USD
|
-15.497%
|
Cellectar Biosciences, Inc.
|
12.07 Million USD
|
-1376.625%
|
Edgewise Therapeutics, Inc.
|
340.03 Million USD
|
47.561%
|
Vaxart, Inc.
|
91.83 Million USD
|
-94.175%
|
PharmaCyte Biotech, Inc.
|
59.9 Million USD
|
-197.662%
|
Aldeyra Therapeutics, Inc.
|
148.32 Million USD
|
-20.215%
|
Cellectis S.A.
|
334.27 Million USD
|
46.657%
|
Longeveron Inc.
|
12.17 Million USD
|
-1364.206%
|
Repare Therapeutics Inc.
|
253.9 Million USD
|
29.771%
|
Sarepta Therapeutics, Inc.
|
3.26 Billion USD
|
94.538%
|
Inozyme Pharma, Inc.
|
200.84 Million USD
|
11.22%
|
Revolution Medicines, Inc.
|
2.08 Billion USD
|
91.463%
|
Nymox Pharmaceutical Corporation
|
1.62 Million USD
|
-10872.985%
|
Third Harmonic Bio, Inc.
|
277.71 Million USD
|
35.793%
|
ArriVent BioPharma, Inc. Common Stock
|
163.09 Million USD
|
-9.328%
|
AN2 Therapeutics, Inc.
|
138.74 Million USD
|
-28.518%
|
Anixa Biosciences, Inc.
|
25.52 Million USD
|
-598.656%
|
Vertex Pharmaceuticals Incorporated
|
22.73 Billion USD
|
99.216%
|
Denali Therapeutics Inc.
|
1.15 Billion USD
|
84.547%
|
Revelation Biosciences, Inc.
|
12.21 Million USD
|
-1360.057%
|
Veru Inc.
|
50.59 Million USD
|
-252.422%
|
Corvus Pharmaceuticals, Inc.
|
45.55 Million USD
|
-291.436%
|
Cingulate Inc.
|
3.49 Million USD
|
-5007.096%
|
Passage Bio, Inc.
|
150.54 Million USD
|
-18.444%
|
Context Therapeutics Inc.
|
16.06 Million USD
|
-1010.091%
|
Exicure, Inc.
|
11.58 Million USD
|
-1439.819%
|
Day One Biopharmaceuticals, Inc.
|
376.04 Million USD
|
52.583%
|
Oramed Pharmaceuticals Inc.
|
161.64 Million USD
|
-10.312%
|
Scinai Immunotherapeutics Ltd.
|
17.47 Million USD
|
-920.553%
|
Rhythm Pharmaceuticals, Inc.
|
332.74 Million USD
|
46.412%
|
Nuvalent, Inc.
|
732.38 Million USD
|
75.653%
|
ABVC BioPharma, Inc.
|
14.94 Million USD
|
-1093.188%
|
Carisma Therapeutics, Inc.
|
89.55 Million USD
|
-99.11%
|
Unicycive Therapeutics, Inc.
|
14.19 Million USD
|
-1156.508%
|
OmniAb, Inc.
|
401.98 Million USD
|
55.642%
|
Anew Medical, Inc.
|
19.45 Million USD
|
-816.486%
|
Fennec Pharmaceuticals Inc.
|
26.72 Million USD
|
-567.168%
|
Lipocine Inc.
|
23 Million USD
|
-675.229%
|
Lexeo Therapeutics, Inc. Common Stock
|
139.8 Million USD
|
-27.541%
|
Nautilus Biotechnology, Inc.
|
305.56 Million USD
|
41.645%
|
SAB Biotherapeutics, Inc.
|
83.94 Million USD
|
-112.424%
|
G1 Therapeutics, Inc.
|
121.54 Million USD
|
-46.71%
|
Bellerophon Therapeutics, Inc.
|
7.93 Million USD
|
-2147.146%
|
Sage Therapeutics, Inc.
|
882.27 Million USD
|
79.79%
|
Ocugen, Inc.
|
64.54 Million USD
|
-176.25%
|
Mind Medicine (MindMed) Inc.
|
124.54 Million USD
|
-43.175%
|
Q32 Bio Inc.
|
306.11 Million USD
|
41.751%
|
Brainstorm Cell Therapeutics Inc.
|
4.2 Million USD
|
-4137.429%
|
Alumis Inc. Common Stock
|
89.61 Million USD
|
-98.981%
|
Equillium, Inc.
|
50.53 Million USD
|
-252.881%
|
Kyverna Therapeutics, Inc.
|
75.19 Million USD
|
-137.131%
|
Coya Therapeutics, Inc.
|
41.27 Million USD
|
-332.023%
|
CNS Pharmaceuticals, Inc.
|
1.7 Million USD
|
-10383.622%
|
Galera Therapeutics, Inc.
|
26.14 Million USD
|
-582.112%
|
Evelo Biosciences, Inc.
|
64.44 Million USD
|
-176.704%
|
Comera Life Sciences Holdings, Inc.
|
3.72 Million USD
|
-4684.159%
|
Dominari Holdings Inc.
|
57.55 Million USD
|
-209.794%
|
Edesa Biotech, Inc.
|
8.89 Million USD
|
-1905.649%
|
vTv Therapeutics Inc.
|
11.01 Million USD
|
-1518.361%
|
Bio-Techne Corporation
|
2.81 Billion USD
|
93.662%
|
Agios Pharmaceuticals, Inc.
|
937.11 Million USD
|
80.972%
|
Harmony Biosciences Holdings, Inc.
|
811.44 Million USD
|
78.026%
|
Prelude Therapeutics Incorporated
|
277.66 Million USD
|
35.782%
|
Candel Therapeutics, Inc.
|
41.7 Million USD
|
-327.584%
|
iTeos Therapeutics, Inc.
|
667.58 Million USD
|
73.29%
|
Nkarta, Inc.
|
378.88 Million USD
|
52.938%
|
BioCardia, Inc.
|
2.98 Million USD
|
-5869.568%
|
Iterum Therapeutics plc
|
26.25 Million USD
|
-579.047%
|